The Pennant Group NASDAQ: PNTG reported second-quarter 2026 results that showed revenue and adjusted earnings growth across its home health, hospice and senior living businesses, prompting the company to raise its full-year outlook.
The Pennant Group, Inc. (PNTG) Q2 2026 Earnings Call Transcript
The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.27 per share a year ago.
The Pennant Group (PNTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.
The average of price targets set by Wall Street analysts indicates a potential upside of 27.6% in The Pennant Group (PNTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The Pennant Group (PNTG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.
The Pennant Group NASDAQ: PNTG reported a sharp increase in first-quarter 2026 revenue and adjusted earnings as growth in its home health and hospice business, continued senior living margin improvement and ongoing integration of newly added operations helped drive results.
The Pennant Group, Inc. (PNTG) Q1 2026 Earnings Call Transcript
The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.27 per share a year ago.
The Pennant Group (PNTG) is well positioned to outperform the market, as it exhibits above-average growth in financials.